This Month in Business
Acquisitions, funding rounds, approvals and IP this month
Mark Hillen |
- Alcon posted its Q2 2017 financial report. During this period, net sales were $1.5 billion (vision care and surgical sales rose by 2 and 3 percent, respectively), and the company made an operating loss of $19 million during that time. Parent company, Novartis, reported a net income over the same period of $2 billion (a rise of $0.2 billion over Q2 2016’s value), with net sales of $12.2 billion, and an operating income of $2.3 billion.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.